![Fabio M. Benedetti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fabio M. Benedetti
No más puestos en curso
Historial de carrera de Fabio M. Benedetti
Antiguos cargos conocidos de Fabio M. Benedetti.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
IMMUNITYBIO, INC. | Corporate Officer/Principal | 01/01/2021 | 01/05/2022 |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Director Técnico/Científico/I+D | 01/01/2005 | 15/09/2006 |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Director Técnico/Científico/I+D | 01/05/2002 | 01/01/2005 |
BRISTOL-MYERS SQUIBB COMPANY | Director Técnico/Científico/I+D | 01/07/1999 | 01/05/2002 |
Apollomics, Inc. (United States)
![]() Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Director Técnico/Científico/I+D | - | - |
Taiho Pharmaceutical Co., Ltd.
![]() Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Director Técnico/Científico/I+D | - | - |
Taiho Oncology, Inc.
![]() Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Director Técnico/Científico/I+D | - | - |
GERON CORPORATION | Director Técnico/Científico/I+D | 01/04/2007 | 10/06/2009 |
Corporate Officer/Principal | 10/06/2009 | - |
Formación de Fabio M. Benedetti.
Brown University | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Japón | 2 |
Islas Caimán | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 7 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 9 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
GERON CORPORATION | Health Technology |
IMMUNITYBIO, INC. | Health Technology |
Empresas privadas | 5 |
---|---|
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Taiho Oncology, Inc.
![]() Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Health Technology |
Taiho Pharmaceutical Co., Ltd.
![]() Taiho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan. | Health Technology |
Apollomics, Inc. (United States)
![]() Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Fabio M. Benedetti
- Experiencia